Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBig Technologies Regulatory News (BIG)

Share Price Information for Big Technologies (BIG)

Share Price is delayed by 15 minutes
Get Live Data
104.50    0.00 (0.00%)
Bid:
104.50
Ask:
106.50
Spread: 2.00 (1.914%)
Market Cap: £305.38m
BIG Live PriceLast checked at - London Stock Exchange

Intraday Big Technologies Share Chart

AGM Statement

28 May 2024 07:00

RNS Number : 8552P
Big Technologies PLC
28 May 2024
 

 

28 May 2024

 

Big Technologies plc

("Big Technologies" or the "Company" and the "Group")

AGM Statement

Big Technologies plc, the UK-based, remote people monitoring technology company provides the following trading update ahead of its Annual General Meeting ("AGM") in London later today.

At the meeting, Simon Collins, Chair of Big Technologies plc will make the following statement:

"Since the announcement of our full year results in March 2024, the Board is pleased to report that the Group continues to perform in line with our expectations for the current year.

In the four months ending April 2024, we have recorded unaudited consolidated revenue of £18.5 million, which is unchanged from that achieved over the same period in 2023. As previously announced, revenues from our contract in Colombia will end in the first half of the year as the customer makes the transition to a new supplier. As a result, revenue is expected to be lower in the second half of the year, versus the first half.

In the US we have started to see some early successes and have added a number of smaller accounts as our new business development efforts gain traction. Overall, the forward visibility from our core global customer base remains excellent - 86% of the revenue from our largest customers is contracted beyond the end of 2026.

Our financial expectations for 2024 are unchanged and the Board remains confident of delivering results in line with current market expectations(1).

Our products and technology deliver benefits for society across the globe. In the criminal justice sector our products facilitate a shift towards rehabilitative community-based sentencing which reduces recidivism and keep communities safer. In the remote care sector our technology helps people live happier, healthier and more independent lives.

Drivers for continued growth across both sectors remain strong in the medium-term. With our clear strategy and market-leading products, we are well positioned to generate strong cash flow and expect a return to growth in 2025 and beyond."

(1) Latest company compiled view of market expectations show adjusted EBITDA of £27.0 million to £29.5 million (stated before share-based payments).

 For further information please contact:

 

Big Technologies

+44 (0) 19 2360 1910

Sara Murray (Chief Executive Officer)

Daren Morris (Chief Financial Officer)

Zeus (Nominated Adviser and Sole Broker)

+44 (0) 20 3829 5000

Dan Bate / Kieran Russell (Investment Banking)

Benjamin Robertson (Equity Capital Markets)

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
AGMSEUSULELSEII
Date   Source Headline
11th Nov 20247:00 amRNSTransaction in Own Shares
7th Nov 20247:00 amRNSTransaction in Own Shares
4th Nov 20247:00 amRNSTransaction in Own Shares
31st Oct 20247:00 amRNSTransaction in Own Shares
29th Oct 20247:00 amRNSTransaction in Own Shares
25th Oct 20247:00 amRNSTransaction in Own Shares
23rd Oct 20242:47 pmRNSDirector/PDMR Shareholding
23rd Oct 20247:00 amRNSTransaction in Own Shares
17th Oct 20247:00 amRNSDirector/PDMR Shareholding
16th Oct 20247:00 amRNSTransaction in Own Shares
15th Oct 20247:00 amRNSTransaction in Own Shares
11th Oct 20248:13 amRNSTransaction in Own Shares
9th Oct 20247:00 amRNSDirector/PDMR Shareholding
8th Oct 20247:00 amRNSTransaction in Own Shares
3rd Oct 20247:00 amRNSTransaction in Own Shares
2nd Oct 20247:01 amRNSTransaction in Own Shares
2nd Oct 20247:00 amRNSDirector/PDMR Shareholding
1st Oct 20247:00 amRNSDirector/PDMR Shareholding
27th Sep 20247:00 amRNSShare Buyback Programme
25th Sep 20247:00 amRNSHalf-year Report
23rd Aug 20247:00 amRNSEBT Share Purchase and Share Transfer
22nd Aug 202410:38 amRNSDirector/PDMR Shareholding
21st Aug 20248:00 amRNSEBT Share Transfer
8th Aug 202411:40 amRNSDirector/PDMR Shareholding
5th Aug 20247:00 amRNSDirector/PDMR Shareholding
19th Jul 202410:36 amRNSNon-Executive Chair to step down
11th Jun 20242:49 pmRNSDirector/PDMR Shareholding
7th Jun 202412:27 pmRNSHolding(s) in Company
5th Jun 20243:53 pmRNSDirector/PDMR Shareholding
29th May 20247:00 amRNSResult of AGM
28th May 20247:00 amRNSAGM Statement
20th May 202411:18 amRNSHolding(s) in Company
26th Apr 202411:28 amRNS2023 Annual Report and Notice of AGM
26th Mar 20247:00 amRNS2023 Preliminary audited results
22nd Feb 202411:35 amRNSHolding(s) in Company
5th Feb 20244:25 pmRNSDirector/PDMR Shareholding
29th Jan 20247:05 amRNSResponse to press speculation
26th Jan 202411:07 amRNSDirector/PDMR Shareholding
23rd Jan 20247:00 amRNSDirector/PDMR Shareholding
23rd Jan 20247:00 amRNSEBT Share Purchase
23rd Jan 20247:00 amRNSDirector/PDMR Shareholding
22nd Jan 20242:23 pmRNSDirector/PDMR Shareholding
22nd Jan 202412:12 pmRNSHolding(s) in Company
19th Jan 20247:04 amRNSTrading Statement
22nd Dec 202311:30 amRNSHolding(s) in Company
21st Dec 20231:35 pmRNSEBT Share Purchase
20th Dec 20232:16 pmRNSDirector/PDMR Shareholding
8th Dec 20233:05 pmRNSDirector/PDMR Shareholding
8th Dec 20237:00 amRNSEBT Share Purchase
6th Dec 20232:06 pmRNSEBT Share Purchase

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.